Trevena Inc
NASDAQ:TRVN
Trevena Inc
Revenue
Trevena Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Trevena Inc
NASDAQ:TRVN
|
Revenue
$3.1m
|
CAGR 3-Years
1%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
37%
|
|
Abbvie Inc
NYSE:ABBV
|
Revenue
$54.3B
|
CAGR 3-Years
6%
|
CAGR 5-Years
11%
|
CAGR 10-Years
11%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Revenue
$27.5B
|
CAGR 3-Years
2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
7%
|
|
Amgen Inc
NASDAQ:AMGN
|
Revenue
$28.2B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
4%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Revenue
$9.9B
|
CAGR 3-Years
17%
|
CAGR 5-Years
26%
|
CAGR 10-Years
23%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Revenue
$13.1B
|
CAGR 3-Years
16%
|
CAGR 5-Years
14%
|
CAGR 10-Years
20%
|
See Also
What is Trevena Inc's Revenue?
Revenue
3.1m
USD
Based on the financial report for Dec 31, 2023, Trevena Inc's Revenue amounts to 3.1m USD.
What is Trevena Inc's Revenue growth rate?
Revenue CAGR 10Y
37%
The average annual Revenue growth rates for Trevena Inc have been 1% over the past three years , -11% over the past five years , and 37% over the past ten years .